Exelixis
EXEL
#1589
Rank
A$19.94 B
Marketcap
A$79.36
Share price
2.89%
Change (1 day)
17.62%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company